Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$32.87−1.03 (-3.04%)
Close on Nov 17, 2026Market cap $1.83BP/E –Yield –
Maze Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Maze Therapeutics's price to sales ratio was 0.1× on Apr 30, 2025.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 0.1× | – |
See a number that looks wrong?